Dr. Oren Becker

Dr. Becker is a co-Founder and member of the Board of Directors of Immunity Pharma. He brings more than 20 years of biopharmaceutical industry and leadership experience, as a serial entrepreneur with expertise in the discovery and development of innovative pharmaceuticals. Dr. Becker is a co-Founder and founding President of R&D for Upstream Bio (Waltham, MA). Formerly he was the President and CEO of Vidac Pharmaceuticals; Founder and CEO of Dynamix Pharmaceuticals; and Founder and CSO of Epix Pharmaceuticals (NASDAQ:EPIX; formerly Predix Pharma). Dr. Becker led or co-led more than $2B worth deals with various pharma companies. He led the discovery and clinical development of 9 drug candidates across oncology, neurology, and inflammatory indications. Prior to that Dr. Becker was a professor at Tel-Aviv University and a visiting professor at Harvard University. He holds a Ph.D. from the Hebrew University of Jerusalem, and a postdoc from Harvard University. Dr. Becker has published more than 50 scientific papers, co-edited two books, and is an inventor of more than 30 patents.